GSGSK GSK · NYSE
$51.05 -0.10% (-$0.05)
- Market cap
- £76.7B
- Enterprise value
- £91.8B
- P/E
- 15.9x
- Forward P/E
- 10.3x
- PEG
- 0.1x
- P/S
- 2.3x
- P/FCF
- 11.0x
- EV/EBITDA
- 8.4x
- ROIC
- 13.9%
- Gross margin
- 72.7%
- Net margin
- 14.5%
- Dividend yield
- 3.57%
- Payout ratio
- 56.8%
- Net debt/EBITDA
- 1.4x
- Beta
- 0.28
- Free float
- 96.9%
About the company
GSK plc is a global pharmaceutical company with a long history and a wide portfolio of medicinal products. The company specializes in researching, developing, and manufacturing drugs for various therapeutic areas, including infectious diseases, respiratory conditions, oncology, immunology, and others. GSK is known for its iconic products and vaccines that help fight diseases worldwide. The company collaborates with research institutions and partners around the world to innovate in the field of medicines and provide new and effective treatment solutions. GSK is also actively working on the development of new vaccines and drugs, including vaccines for COVID-19. GSK plc (GSK) shares may be an interesting choice for investors who follow the pharmaceutical industry and seek investment opportunities in a long-established company with innovative research and a wide portfolio of medicinal products.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Luke Victor Miels
Employees
66,841
Headquarters
London
Valuation
Is today's price reasonable?
- What speaks for it: You pay 15.9 GBP for 1 GBP of yearly profit, little for its sector.
Growth and estimates
Is it growing, and what comes next?
- What to watch: Earnings per share fell by 8.8% a year over the last 3 years.
- What to watch: Earnings per share swing sharply from year to year.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 GBP of revenue, 15 GBP is left as net profit.
- What speaks for it: It earns 14 GBP a year on every 100 GBP of invested capital.
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number